نتایج جستجو برای: mrd

تعداد نتایج: 1567  

Journal: :Neoplasma 2014
J Kusenda M Fajtova A Kovarikova

In this review, we discuss methodological principles and clinical applications of minimal residual disease (MRD) assays based on multiparameter flow cytometry (MFC). The introduction of methods for MRD detection has revolutionized monitoring of treatment response in acute leukemia. Great progress has been made in the development of wide array of flow cytometric techniques for rare event detecti...

Journal: :Blood 2009
Renato Bassan Orietta Spinelli Elena Oldani Tamara Intermesoli Manuela Tosi Barbara Peruta Giuseppe Rossi Erika Borlenghi Enrico M Pogliani Elisabetta Terruzzi Pietro Fabris Vincenzo Cassibba Giorgio Lambertenghi-Deliliers Agostino Cortelezzi Alberto Bosi Giacomo Gianfaldoni Fabio Ciceri Massimo Bernardi Andrea Gallamini Daniele Mattei Eros Di Bona Claudio Romani Anna Maria Scattolin Tiziano Barbui Alessandro Rambaldi

Clinical risk classification is inaccurate in predicting relapse in adult patients with acute lymphoblastic leukemia, sometimes resulting in patients receiving inappropriate chemotherapy or stem cell transplantation (SCT). We studied minimal residual disease (MRD) as a predictive factor for recurrence and as a decisional tool for postconsolidation maintenance (in MRD(neg)) or SCT (in MRD(pos))....

2017
Rania A. Ghonaim Tarek A. Elgohary R. A. Ghonaim T. A. Elgohary

Background: After achieving morphological remission, existence of few number of leukemic cells in the patient’s blood represents the minimal residual disease (MRD) and its monitoring helps in evaluating early treatment response and future relapse. Patients and methods: Eighty seven newly diagnosed (B-ALL) cases were enrolled in the present study in the time period from October 2013 to October 2...

2018
David O’Connor Amir Enshaei Jack Bartram Jeremy Hancock Christine J. Harrison Rachael Hough Sujith Samarasinghe Claire Schwab Ajay Vora Rachel Wade John Moppett Anthony V. Moorman Nick Goulden

Purpose Minimal residual disease (MRD) and genetic abnormalities are important risk factors for outcome in acute lymphoblastic leukemia. Current risk algorithms dichotomize MRD data and do not assimilate genetics when assigning MRD risk, which reduces predictive accuracy. The aim of our study was to exploit the full power of MRD by examining it as a continuous variable and to integrate it with ...

Journal: :American journal of clinical pathology 2009
Adhra Al-Mawali David Gillis Ian Lewis

The presence of minimal residual disease (MRD) in the bone marrow (BM) of patients with acute myeloid leukemia (AML) following chemotherapy has been established by many studies to be strongly associated with relapse of leukemia. In addition, detection of MRD is the major objective of many of the newer diagnostic techniques used in malignant hematology. Because of the wide availability and conce...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2001
M He P J Sheldon D H Sherman

Self-protection in the mitomycin C (MC)-producing microorganism Streptomyces lavendulae includes MRD, a protein that binds MC in the presence of NADH and functions as a component of a unique drug binding-export system. Characterization of MRD revealed that it reductively transforms MC into 1,2-cis-1-hydroxy-2,7-diaminomitosene, a compound that is produced in the reductive MC activation cascade....

2012
Rada M. Grubovikj Asif Alavi Ahrin Koppel Mary Territo Gary J. Schiller

Allogeneic hematopoietic stem cell transplantation (allo-SCT) is potentially curative for patients with high-risk leukemia, but disease recurrence remains the leading cause of treatment failure. Our objective was to determine the impact of minimal residual disease (MRD) by any technique in adult patients with acute myeloid leukemia (AML) in morphologic first and second complete remission underg...

2012
Monika Brüggemann Thorsten Raff Michael Kneba

Significant improvements have been made in the treatment of acute lymphoblastic leukemia (ALL) during the past 2 decades, and measurement of submicroscopic (minimal) levels of residual disease (MRD) is increasingly used to monitor treatment efficacy. For a better comparability of MRD data, there are ongoing efforts to standardize MRD quantification using real-time quantitative PCR of clonal imm...

2013
Suk Hang Cheng Kin Mang Lau Chi Kong Li Natalie P. H. Chan Rosalina K. L. Ip Chi Keung Cheng Vincent Lee Matthew M. K. Shing Alex W. K. Leung Shau Yin Ha Daniel K. L. Cheuk Anselm C. W. Lee Chak Ho Li Chung Wing Luk Siu Cheung Ling Ondrej Hrusak Ester Mejstrikova Yonna Leung Margaret H. L. Ng

Minimal residual disease, or MRD, is an important prognostic indicator in childhood acute lymphoblastic leukemia. In ALL-IC-BFM 2002 study, we employed a standardized method of flow cytometry MRD monitoring for multiple centers internationally using uniformed gating, and determined the relevant MRD-based risk stratification strategies in our local patient cohort. We also evaluated a novel metho...

Journal: :Blood 2012
Monika Brüggemann Thorsten Raff Michael Kneba

Significant improvements have been made in the treatment of acute lymphoblastic leukemia (ALL) during the past 2 decades, and measurement of submicroscopic (minimal) levels of residual disease (MRD) is increasingly used to monitor treatment efficacy. For a better comparability of MRD data, there are ongoing efforts to standardize MRD quantification using real-time quantitative PCR of clonal imm...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید